Clinical Validation Study of Comfilcon A Multifocal Toric Contact Lenses
- Conditions
- Presbyopia
- Interventions
- Device: Comfilcon A lens (test)Device: Omafilcon B lens (control)
- Registration Number
- NCT03417557
- Lead Sponsor
- Coopervision, Inc.
- Brief Summary
This is a study to evaluate the clinical performance and subjective acceptance of an investigational contact lens (test), compared to a marketed lens (control) in an in-office setting.
- Detailed Description
This is a study to evaluate the clinical performance (including visual acuity, subjective assessments of visual performance, comfort ratings, vision preference and lens fit) of a comfilcon A investigational contact lens (test) compared to a control contact lens, in a non-dispensing setting. The main study hypothesis is the test contact lens will not be clinically inferior to the control lens.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
- Has had a self-reported oculo-visual examination in the last two years.
- Is between ages 40-75 years, inclusive and has full legal capacity to volunteer.
- Has read and understood the information consent letter. Is willing and able to follow instructions and maintain the appointment schedule.
- Is able to participate in Parts A and B related to this work.
- Has a contact lens spherical prescription between +10.00 to 10.00D (inclusive).
- Has an Add component to their spectacle refraction (between +0.75 and +2.50DS).
- Has astigmatism between of -0.75 and -5.75DC (based on the calculated ocular refraction) in each eye.
- Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/25 best-corrected.
- Currently wears soft contact lenses.
- Has clear corneas and no active ocular disease.
- Has not worn lenses for at least 12 hours before the examination.
A person will be excluded from the study if he/she:
- Has never worn contact lenses before.
- Has any systemic disease affecting ocular health.
- Is using any systemic or topical medications that will affect ocular health.
- Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
- Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
- Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
- Is aphakic.
- Has undergone corneal refractive surgery.
- Is participating in any other type of eye related clinical or research study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Comfilcon A lens (test) Comfilcon A lens (test) Subjects are randomized to wear comfilcon A lens for up to 3 hours, either as first or second lens during this cross over study. Omafilcon B Lens (control) Omafilcon B lens (control) Subjects are randomized to wear omafilcon B lens for up to 3 hours, either as first or second lens during this cross over study.
- Primary Outcome Measures
Name Time Method Visual Acuity up to 3 hours Visual acuity is assessed for test and control lens on a logMAR chart
- Secondary Outcome Measures
Name Time Method Subjective Assessment of Visual Performance: Distance Day-time Navigation Tasks for Vision Quality and Clarity up to 3 hours Subjective assessment of visual performance for distance day-time navigation tasks for vision/clarity was assessed for test and control lens at different testing distances. Scale 0-100, 0=poor, 100=excellent.
Subjective Assessment of Visual Performance: Intermediate / Computer Task for Vision Quality and Clarity up to 3 hours Subjective assessments of visual performance for intermediate / computer tasks for vision quality and clarity were assessed for test and control lens at different testing distances. Scale 0-100, 0=poor, 100=excellent.
Subjective Assessment of Visual Performance: Near Vision for Vision Quality and Clarity up to 3 hours Subjective assessments of visual performance for near vision was assessed for vision quality and clarity for test and control lens at different testing distances. Scale 0-100, 0=poor, 100=excellent.
Trial Locations
- Locations (1)
Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University
🇺🇸Bloomington, Indiana, United States